31 of 58



Mark Bondi JUNE 5 FINAL.wmv
With the recent publications of the NIA-Alzheimer’s Association workgroups on revising the criteria for diagnosis of dementia due to Alzheimer’s disease, it is clear we are entering an era increasingly focused on the role of biomarkers in disease detection, diagnosis, and predicting clinical outcome.  Dr. Mark Bondi, Professor of Psychiatry at the University of California San Diego, will review evidence of the relative value of genetic, imaging, and CSF markers in the early detection and diagnosis of AD. PLEASE NOTE: CEUs are no longer available for this session.
Comments Disabled